Literature DB >> 7523004

Central nervous system abnormalities in chromosome deletion at 11q23.

J Ono1, K Harada, T Hasegawa, K Sakurai, R Kodaka, Y Tanabe, J Tanaka, T Igarashi, T Nagai, S Okada.   

Abstract

Two Japanese pediatric patients with terminal deletion of the long arm of chromosome 11 are described. Both had the morphological abnormalities of the 11q deletion syndrome, such as prominent epicanthal folds, broad flat nasal bridge with short, upturned nose, short philtrum with carp-shaped mouth, cardiac anomalies and nonprogressive moderate psychomotor developmental delay. Patient 1 is the first case to be reported with 11q deletion with serial magnetic resonance (MR) examinations of cerebral white matter. The initial MR imaging studies demonstrated multiple areas of T1 and T2 prolongation in the cerebral white matter in both patients at the ages of 2 5/12 and 2 1/12 years, respectively. A second MR imaging, performed 1 year after the first in Patient 1, demonstrated slight improvement of the lesions. Neither patient showed clinical deterioration. These results suggest that the lesions were caused by delayed myelination, rather than by demyelination. It is suggested that an unknown factor which is important for myelination is located on the long arm of chromosome 11: perhaps the neural cell adhesion molecule (NCAM).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523004     DOI: 10.1111/j.1399-0004.1994.tb04042.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  2 in total

1.  NCAM1 is the Target of miRNA-572: Validation in the Human Oligodendroglial Cell Line.

Authors:  Roberta Mancuso; Simone Agostini; Ivana Marventano; Ambra Hernis; Marina Saresella; Mario Clerici
Journal:  Cell Mol Neurobiol       Date:  2017-03-22       Impact factor: 5.046

2.  MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression.

Authors:  Roberta Mancuso; Ambra Hernis; Simone Agostini; Marco Rovaris; Domenico Caputo; Mario Clerici
Journal:  J Transl Med       Date:  2015-05-07       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.